Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Conconi, Giovanni Martinelli, A. López-Guillermo, P. Zinzani, A. Ferreri, L. Rigacci, L. Devizzi, U. Vitolo, S. Luminari, F. Cavalli, Emanuele Zucca (2011)Clinical activity of bortezomib in relapsed/refractory MALT lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group (IELSG).
Annals of oncology : official journal of the European Society for Medical Oncology, 22 3
A. Salar, E. Domingo-Domènech, C. Estany, M. Canales, F. Gallardo, O. Servitje, G. Fraile, C. Montalbán (2009)Combination therapy with rituximab and intravenous or oral fludarabine in the first‐line, systemic treatment of patients with extranodal marginal zone B‐cell lymphoma of the mucosa‐associated lymphoid tissue type
M. Raderer, S. Wöhrer, B. Streubel, M. Troch, K. Turetschek, U. Jäger, C. Skrabs, A. Gaiger, J. Drach, A. Puespoek, M. Formanek, M. Hoffmann, W. Hauff, A. Chott (2006)Assessment of disease dissemination in gastric compared with extragastric mucosa-associated lymphoid tissue lymphoma using extensive staging: a single-center experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24 19
L. Arcaini, S. Burcheri, A. Rossi, F. Passamonti, M. Paulli, E. Boveri, E. Brusamolino, E. Orlandi, A. Molteni, A. Pulsoni, M. Cox, L. Orsucci, A. Fabbri, M. Frezzato, M. Voso, F. Zaja, F. Montanari, C. Pascutto, E. Morra, S. Cortelazzo, M. Lazzarino (2006)Nongastric marginal-zone B-cell MALT lymphoma: prognostic value of disease dissemination.
The oncologist, 11 3
M. Troch, C. Jonak, L. Müllauer, A. Püspök, M. Formanek, W. Hauff, C. Zielinski, A. Chott, M. Raderer (2009)A phase II study of bortezomib in patients with MALT lymphoma
E. Song, S.Y. Kim, T. Kim, K. Lee, T. Yun, I. Na, H. Shin, S. Lee, D. Kim, S. Khwarg, D. Heo (2008)Efficacy of chemotherapy as a first-line treatment in ocular adnexal extranodal marginal zone B-cell lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology, 19 2
A Conconi, G Martinelli (2011)Lopez-Guillermo A Clinical activity of bortezomib in relapsed/refractory MALT lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group (IELSG)
Ann Oncol., 22
A. Ruskoné-Fourmestraux, W. Fischbach, B. Aleman, H. Boot, M. Du, F. Mégraud, C. Montalbán, M. Raderer, A. Savio, A. Wotherspoon (2011)EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT
E. Zucca, A. Conconi, E. Pedrinis, S. Cortelazzo, T. Motta, M. Gospodarowicz, B. Patterson, A. Ferreri, M. Ponzoni, L. Devizzi, R. Giardini, G. Pinotti, C. Capella, P. Zinzani, S. Pileri, A. López-Guillermo, E. Campo, A. Ambrosetti, L. Baldini, F. Cavalli (2003)Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue.
Blood, 101 7
A. Ferreri, G. Dognini, M. Ponzoni, L. Pecciarini, M. Cangi, G. Santambrogio, A. Resti, C. Conciliis, S. Magnino, E. Pasini, N. Vicari, R. Dolcetti, C. Doglioni (2008)Chlamydia-psittaci-eradicating antibiotic therapy in patients with advanced-stage ocular adnexal MALT lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology, 19 1
Y. Ishimatsu, H. Mukae, Kiyoshi Matsumoto, T. Harada, A. Hara, Shintaro Hara, M. Amenomori, Hanako Fujita, N. Sakamoto, Tomayoshi Hayashi, S. Kohno (2010)Two cases with pulmonary mucosa-associated lymphoid tissue lymphoma successfully treated with clarithromycin.
Chest, 138 3
G. Jäger, P. Neumeister, R. Brezinschek, T. Hinterleitner, W. Fiebiger, M. Penz, H. Neumann, B. Mlineritsch, M. Desantis, F. Quehenberger, A. Chott, C. Beham‐Schmid, G. Höfler, W. Linkesch, M. Raderer (2002)Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 20 18
T. Kim, Ki Kim, Min Lee, Y. Jeon, Se-Hoon Lee, Dong-Wan Kim, C. Kim, I. Kim, S. Khwarg, D. Heo (2010)First‐line therapy with doxycycline in ocular adnexal mucosa‐associated lymphoid tissue lymphoma: A retrospective analysis of clinical predictors
Cancer Science, 101
M. Hoffmann, M. Troch, H. Eidherr, T. Traub-Weidinger, C. Jonak, L. Muellauer, M. Raderer (2011)90Y-ibritumomab tiuxetan (Zevalin) in heavily pretreated patients with mucosa associated lymphoid tissue lymphoma
Leukemia & Lymphoma, 52
M. Raderer, B. Streubel, S. Woehrer, A. Puespoek, U. Jaeger, M. Formanek, A. Chott (2005)High Relapse Rate in Patients with MALT Lymphoma Warrants Lifelong Follow-up
Clinical Cancer Research, 11
S. Govi, G. Dognini, G. Licata, R. Crocchiolo, A. Resti, M. Ponzoni, A. Ferreri (2010)Six‐month oral clarithromycin regimen is safe and active in extranodal marginal zone B‐cell lymphomas: final results of a single‐centre phase II trial
British Journal of Haematology, 150
S. Bayraktar, U. Bayraktar, A. Stefanovic, I. Lossos (2011)Primary ocular adnexal mucosa‐associated lymphoid tissue lymphoma (MALT): single institution experience in a large cohort of patients
British Journal of Haematology, 152
B. Esmaeli, P. Mclaughlin, B. Pro, F. Samaniego, Isis Gayed, F. Hagemeister, J. Romaguera, F. Cabanillas, S. Neelapu, R. Banay, L. Fayad, M. Saville, L. Kwak (2009)Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology, 20 4
A. Aigelsreiter, Tanja Gerlza, A. Deutsch, E. Leitner, C. Beham‐Schmid, A. Beham, H. Popper, N. Borel, A. Pospischil, M. Raderer, H. Kessler, P. Neumeister (2011)Chlamydia psittaci Infection in nongastrointestinal extranodal MALT lymphomas and their precursor lesions.
American journal of clinical pathology, 135 1
J. Goda, L. Le, Normand Lapperriere, B. Millar, D. Payne, M. Gospodarowicz, W. Wells, D. Hodgson, A. Sun, R. Simpson, R. Tsang (2011)Localized orbital mucosa-associated lymphoma tissue lymphoma managed with primary radiation therapy: efficacy and toxicity.
International journal of radiation oncology, biology, physics, 81 4
B. Grünberger, S. Wöhrer, B. Streubel, M. Formanek, V. Petkov, A. Puespoek, M. Haefner, M. Hejna, U. Jaeger, A. Chott, M. Raderer (2006)Antibiotic treatment is not effective in patients infected with Helicobacter pylori suffering from extragastric MALT lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24 9
C. Thieblemont, F. Berger, C. Dumontet, I. Moullet, F. Bouafia, P. Felman, G. Salles, B. Coiffier (2000)Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed.
Blood, 95 3
H. Gill, C. Chim, W. Au, F. Loong, E. Tse, A. Leung, Y. Kwong (2011)Non-gastric marginal zone B cell lymphoma: clinicopathologic features and treatment results
Annals of Hematology, 90
S. Oh, W. Kim, Jin Kim, S. Kim, H. Kwon, Dae-Ho Lee, J. Won, I. Hwang, M. Kim, S. Lee, Y. Chae, Deok-Hwan Yang, Gyeong-Won Lee, C. Choi, Jinny Park, C. Suh, Hyo-jin Kim (2010)Pulmonary marginal zone B-cell lymphoma of MALT type—What is a prognostic factor and which is the optimal treatment, operation, or chemotherapy?: Consortium for Improving Survival of Lymphoma (CISL) Study
Annals of Hematology, 89
J. Goda, M. Gospodarowicz, M. Pintilie, W. Wells, D. Hodgson, A. Sun, M. Crump, R. Tsang (2010)Long‐term outcome in localized extranodal mucosa‐associated lymphoid tissue lymphomas treated with radiotherapy
Dandan Zhang, Lina Dong, Haiyan Li, Ha-si Jin, H. Ye, Xiao‐ge Zhou, Zi-fen Gao, G. Dong, Jianbo Zhu, Honggang Liu, L. Gong (2010)Ocular adnexal mucosa-associated lymphoid tissue lymphoma in Northern China: high frequency of numerical chromosomal changes and no evidence of an association with Chlamydia psittaci
Leukemia & Lymphoma, 51
C. Kalpadakis, G. Pangalis, T. Vassilakopoulos, M. Kyrtsonis, M. Siakantaris, F. Kontopidou, P. Korkolopoulou, Panagia Bobotsis, Sotirios Sahanas, T. Tzenou, D. Anagnostou, Evangelia Dimitriadou, X. Yiakoumis, E. Patsouris, Panagiota Roussou, P. Panayiotidis, E. Papadaki, M. Angelopoulou (2008)Non-gastric extra-nodal marginal zone lymphomas–a single centre experience on 76 patients
Leukemia & Lymphoma, 49
Guidelines and algorithms for the management of gastric mucosa-associated lymphoid tissue (MALT) lymphoma have been developed in the recent past, but the situation regarding nongastric MALT lymphomas is much more complicated. Owing to the heterogeneity of MALT lymphomas arising in various organs, different approaches to treatment have been applied, mostly in an uncontrolled fashion. In the recent past, for example, attempts to use antibiotic therapy in managing ocular adnexal MALT lymphomas have been reported, with response rates varying between 0% and 60% with the use of doxycycline or, more rarely, clarithromycin. Currently, antibiotic therapy remains experimental, with conflicting data and apparent geographic variations. In addition, there is no clear consensus whether radiation or systemic therapy is more effective in MALT lymphomas at different locations, including the lung and the ocular adnexa. This review highlights and briefly discusses some recent developments in the management of nongastric MALT lymphomas.
Current Hematologic Malignancy Reports – Springer Journals
Published: Aug 2, 2011
Access the full text.
Sign up today, get DeepDyve free for 14 days.